These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4815306)

  • 1. Intra-amniotic prostaglandin F-2 alpha and urea for abortion.
    Craft I; Walker E; Youssefnejadian E
    Prostaglandins; 1974 Feb; 5(4):397-406. PubMed ID: 4815306
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex steroid hormone levels in plasma following intra-amniotic injection of urea and prostaglandin E2.
    Craft IL; Fergusson IL; Smith B; Youssefnejadian E
    J Obstet Gynaecol Br Commonw; 1973 Dec; 80(12):1095-9. PubMed ID: 4761383
    [No Abstract]   [Full Text] [Related]  

  • 3. Intra-amniotic prostaglandin techniques for induction of mid-trimester abortion and associated changes in plasma steroid hormones.
    Craft I; Youssefnejadian E
    S Afr Med J; 1974 Oct; 0(0):Suppl:31-5. PubMed ID: 4417496
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma hormone profiles following high-dose intraamniotic prostaglandin F2alpha.
    Craft I; Carriere E; Youssefnejadian E
    Obstet Gynecol; 1974 Jul; 44(1):135-41. PubMed ID: 4834807
    [No Abstract]   [Full Text] [Related]  

  • 5. Intra-amniotic urea and prostaglandin E2 for abortion. A clinical study to determine the efficacy of using a variable prostaglandin dosage.
    Craft I
    Prostaglandins; 1973 Nov; 4(5):755-63. PubMed ID: 4781519
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of abortion by combined intra-amniotic urea and prostaglandin E 2 or prostaglandin E 2 alone.
    Craft I
    Lancet; 1973 Jun; 1(7816):1344-6. PubMed ID: 4122740
    [No Abstract]   [Full Text] [Related]  

  • 7. Termination of early gestation with intramuscular (15S)-15 methyl prostaglandin F2 alpha.
    Brenner PF; Lumkin ME; Ballard C; Mishell DR
    Contraception; 1975 Mar; 11(3):279-87. PubMed ID: 1116367
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma hormone changes during infusions of prostaglandins F2alpha and E2 for therapeutic abortion.
    Newton J; Collins W
    Adv Biosci; 1973; 9():689-99. PubMed ID: 4805881
    [No Abstract]   [Full Text] [Related]  

  • 9. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
    Sher G; Katz M
    Acta Obstet Gynecol Scand; 1978; 57(3):223-5. PubMed ID: 665164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-amniotic prostaglandin for induction of abortion: an improved regime using prostaglandin E2.
    Mackenzie IZ; Embrey MP; Hillier K
    J Obstet Gynaecol Br Commonw; 1974 Jul; 81(7):554-7. PubMed ID: 4843761
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone changes in relation to the time of fetal death after prostaglandin-induced abortion.
    Fraser IS; Nicholson KM; Graham G; Boyle H
    Prostaglandins; 1977 Jun; 13(6):1161-7. PubMed ID: 887804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of fall in plasma progesterone and time to abortion following intra-amniotic injection of prostaglandin F2alpha, with or without urea, in the second trimester of human pregnancy.
    Walker SM; Flint AP; Turnbull AC
    Br J Obstet Gynaecol; 1975 Jun; 82(6):488-92. PubMed ID: 1138838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of prostaglandin f-2-alpha as an abortifacient.
    Kajanoja P; Widholm O
    Ann Chir Gynaecol Fenn; 1974; 63(1):28-34. PubMed ID: 4832153
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in estrogen levels in maternal venous plasma after intra-amniotic infusion of prostaglandin F2 for therapeutic abortion.
    Shutt DA; Smith ID; Shearman RP
    Prostaglandins; 1973 Aug; 4(2):291-9. PubMed ID: 4729615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of early gestation with vaginal prostaglandin F2 alpha tablets.
    Corlett RC; Sribyatta B; Mishell DR; Ballard C; Nakamura RM; Thorneycroft IH
    Prostaglandins; 1972 Dec; 2(6):453-64. PubMed ID: 4666665
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Changes in oestrone, oestradiol-17beta and oestriol levels in maternal venous plasma after intra-amniotic infusion of prostaglandin F 2alpha for therapeutic abortion.
    Shutt DA; Smith ID; Shearman RP
    J Reprod Fertil; 1974 Feb; 36(2):478-9. PubMed ID: 4819348
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravaginal PGE2 in early abortion.
    Jones JR; Perez RJ
    Prostaglandins; 1974 Jul; 7(2):149-63. PubMed ID: 4852554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of therapeutic abortion using either extra-amniotic prostaglandin F-2-alpha or hypertonic saline followed by oxytocin.
    Lange AP; Secher NJ; Pedersen GT
    Prostaglandins; 1974 Apr; 6(2):149-57. PubMed ID: 4847514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of abortion with prostaglandin F2 alpha. Intravenous, extra-amniotic and intra-amniotic administration].
    Lindmark G; Nilsson BA; Nyberg R; Zador G
    Lakartidningen; 1973 Oct; 70(44):3939-43. PubMed ID: 4787903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.